ICIS 2014* , ,
Presentations this author is a contributor to:
MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases (#30)
3:00 PM
Rebecca C Coll
Concurrent Mini-Symposium 1
MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel therapeutic for NLRP3 driven diseases (#237)
6:00 PM
Matthew A Cooper
Poster Session 1